Key facts
- It has raised $150K; the latest was Seed Round ($150K) in Apr 2025.
- Notable investors include Bio4Dreams, Hub Innovazione Trentino.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for wonderGene
- ·The full record, as it builds
Funding rounds
No funding rounds for wonderGene are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About wonderGene
Operator of an anatomic pathology laboratory intended to offer innumerable tests and combinations. The company's tests include routine screening to highly esoteric molecular and genetic assays such as anatomic pathology, genetic, pain management, pediatric, and various disease detection, enabling clinicians to diagnose and monitor disease in patients and hospitals to improve patient care.
- Sector
- Healthcare
- HQ
- Trento, Italy
- Founded
- 2018
- Employees
- 7
- Website
- wondergene.bio/
- Ownership
- Privately Held (backing)
wonderGene doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in wonderGene shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on wonderGene in its N-PORT filings yet. We sweep new filings monthly.